Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ivermectin vs Permethrin 5% Lotion in Treatment of Pediculosis Capitis
NCT05643820Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of CHILD-IVITAB in pediculosis capitis (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Treatment Success of Pediculosis Capitis at 14 days. Started Mar 2022; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT05643820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05643820.